Policy Brief

Issue No. 29

Unveiling Thailand’s Path to Open Data for Health Policy

Issue No. 27

eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India

Issue No. 28

Implementation of a Virtual Consultation Platform (VCP) for Healthcare Providers Integrated with a Patient-Facing Mobile Application

Issue No. 26

Rare diseases – Talk of the Town for Some Time but What’s Next?

By : Phornnaphat Chertchinnapa, Annapoorna Prakash

Issue No. 25

South Korea’s Experience of Reimbursing High-Cost Medicines

By : Dr. Dimple Butani

Issue No. 24

Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

By : Kumaree Pachanee, Dian Faradiba

Issue No. 149

Health Financing during COVID-19 responses in Thailand

By : Papada Ranron, Praewa Kulatnam, Aungsumalee Pholpark, Sikarn lssarachaiyos

Issue No. 23

Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs

By : Dian Faradiba

Issue No. 22

Horizon Scanning in the European Union

By : Dian Faradiba, Dr. Dimple Butani, Mr. Nyi Nyi Zayar

Issue No. 21

The Life Saving Drug Program: Australia’s pathway to high-cost drugs

By : Evan Huang-Ku, Dr. Tracey Laba

Issue No. 145

Unpacking Digital Health: A breakdown of concepts and definitions

By : Dr. Dimple Butani

Issue No. 142

High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand

By : Wanrudee Isaranuwatchai, PhD, Picharee Karunayawong, Dr. Piyada Gaewkhiew, Chulathip Boonma, Myka Harun Sarajan